Skip to main content
Friday
November 29, 2024
Sign In
Subscribe
Home
Epaper
Economy
Aviation
Banking
Bazaar
Budget
Industry
NBR
RMG
Corporates
Stocks
Analysis
Videos
Podcast
World+Biz
Features
Book Review
Brands
Earth
Explorer
Food
Habitat
In Focus
Luxury
Mode
Panorama
Pursuit
Wheels
Subscribe
Epaper
GOVT. Ad
More
Sports
TBS Graduates
Thoughts
Splash
Bangladesh
Supplement
Infograph
Archive
Gallery
Long Read
Interviews
Offbeat
Tech
Magazine
Climate Change
Health
Cartoons
বাংলা
FRIDAY,
NOVEMBER 29, 2024
Moderna Inc
World+Biz
Moderna reports positive results for RSV vaccine
Coronavirus chronicle
Moderna raises full-year Covid vaccine sales forecast to $21 billion
Global Economy
Covid vaccine maker Moderna flags Japan ambition with sumo sponsorship
Coronavirus chronicle
Moderna plots vaccines against 15 pathogens with future pandemic potential
Coronavirus chronicle
Moderna cuts 2021 sales forecast for Covid-19 vaccine; shares tumble
Coronavirus chronicle
US FDA clears Moderna, J&J Covid-19 boosters, backs use of different vaccine for boost
Coronavirus chronicle
Pfizer, Moderna vaccines stop infections in real-world study
Coronavirus chronicle
UK begins rollout of Moderna Covid vaccine in Wales
Coronavirus chronicle
Pfizer, Moderna Covid-19 vaccines highly effective after first shot in real-world use, US study shows
Coronavirus chronicle
Moderna begins study of Covid-19 vaccine in kids
Global Economy
AstraZeneca has sold its stake in Moderna for more than $1 billion: The Times
Analysis
What J&J's authorized Covid-19 shot means for the US vaccination campaign
Coronavirus chronicle
Moderna wants to pack 50pc more Covid vaccine per vial
Show More